Skip to content

Clinical trials

Scleroderma, Systemic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Country / region: China Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20151
20172
20191
20211
20224
20236
202414
202528
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting40
Not yet recruiting12
Unknown status10
Active, not recruiting4
Suspended3
Enrolling by invitation2
Completed2
Withdrawn2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing GoBroad Hospital5
China Immunotech (Beijing) Biotechnology Co., Ltd.4
Nanjing Bioheng Biotech Co., Ltd.4
Peking University Third Hospital4
RenJi Hospital4
The Children's Hospital of Zhejiang University School of Medicine4
Boehringer Ingelheim3
PersonGen BioTherapeutics (Suzhou) Co., Ltd.3
Tongji Hospital3
Anhui Provincial Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic76
Lupus Erythematosus, Systemic40
Myositis30
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis27
Sjogren's Syndrome19
Autoimmune Diseases17
Antiphospholipid Syndrome12
Arthritis, Rheumatoid12
Immunoglobulin G4-Related Disease6
Lung Diseases, Interstitial4

Trials

Showing 26 to 50 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.